Navigation Links
Mindray Medical International Announces First Quarter 2008 Results
Date:5/7/2008

(41,265) (60,304) (8,600)

Other general expenses (37) (44) (6)

Operating income 124,607 199,759 28,488

Other income, net 3,164 3,596 513

Interest income 17,560 16,884 2,408

Interest expense (96) (35) (5)

Income before income taxes and

minority interests 145,235 220,204 31,404

Provision for income taxes (22,866) (40,837) (5,824)

Minority interests -- -- --

Net Income 122,369 179,367 25,580

Basic earnings per share 1.16 1.68 0.24

Diluted earnings per share 1.09 1.59 0.23

Shares used in the computation

of:

Basic earnings per share 105,743,984 106,962,659 106,962,659

Diluted earnings per share 111,869,215 112,998,260 112,998,260

(2) Share-based compensation

charges incurred during the

period related to:

Cost of revenues 349 789 113

Selling expenses 4,892 5,767 822

General and administrative

expenses 4,022 4,091 583

Research and development

expenses 4,000 5,357 764

Exhibit 3

MINDRAY MEDICAL INTERNATIONAL LIMITED RECONCILIATIONS OF NON-GAAP RESULTS OF OPERATIONS MEASURES TO THE NEAREST

COMPARABLE GAAP MEASURES

Three months ended March 31,


'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. ATS Medical Expands Open Pivot Heart Valve Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... Total impact of NC,s biotechnology sector is $45....LE PARK, N.C., Nov. 20 ...n its expanding biotechnology enterprise during th...ceeds $45 billion, according to data released toda... , Norris Tolson, president and CEO of the Bio...
(Date:11/20/2008)... SAN DIEGO, Nov. 20 Neur...ced today that Kevin Gorman, President and Chief,...e presenting at the 20th,Annual Piper Jaffray Hea... "fireside chat" presentation takes place Tuesday,.../10:30 a.m. Pacific Time (PT). The,presentation w...
(Date:11/20/2008)... LENEXA, Kan., Nov. 20 KansasBio a...itiative to promote the region,s human,health-car...re drug,development continuum. Called the Nationa... the alliance comprises companies across Kansas an...t many of the nation,s preferred resources,for dr...
(Date:11/20/2008)... LONGMONT, Colo., Nov. 20 MicroPha...unced it has concluded its latest round,of financ...ion. Investors in,this round were a combination ... have come from private investors. , MicroP...ete the validation,and launch preparation of thei...
Breaking Biology Technology:North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 2North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 3North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 4North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 5National Drug Development Accelerator Launched 2MicroPhage Closes Latest Financing 2
... technology managers in healthcare received a heav...eld during the opening session of WTN Media,s Dig...ich is being held May 3 and 4 at the Fluno Center ...tured an opening panel discussion in which there w...he industry has come with information systems. Nor...
...lanning will accomplish more in preparing for the ...than will any reliance on information technology, ...rence were told. , ,Panelists talked about being ...detect and mitigate the effects of a flu pandemic,... disruptions before running its course. , ,For hea...
...site in your industry is a noble goal, a far more ... ,The best means of measuring your web site,s popu...t is, the number and quality of other web sites li...k to your web site, it,s a vote of confidence in y...idence is inherited by search engines which reward...
...are of managing liability in identity theft cases ...,s Digital Healthcare Conference, and healthcare p...od it would be. , ,Using a hypothetical case of id...s from Michael Best & Friedrich demonstrated how...emselves in even when they take steps to prevent s...
Other Biology Technology:Digital Healthcare Conference starts on a realistic note 2Digital Healthcare Conference starts on a realistic note 3IT may take a back seat in fighting avian flu 2IT may take a back seat in fighting avian flu 3IT may take a back seat in fighting avian flu 4Link Popularity: The Internet's 'In' Crowd 2Link Popularity: The Internet's 'In' Crowd 3Managing the nightmare of identity theft 2Managing the nightmare of identity theft 3Managing the nightmare of identity theft 4
(Date:11/20/2008)...swire/ -- DigitalPersona, Inc., the,leader in fin...alPersona,Personal 4.0, an easy-to-use identity p...nd business users. DigitalPersona Personal 4.0 is ...rics, letting people use their fingerprints to,ac...shopping, and other Web,sites -- to provide a cri...
(Date:11/20/2008)... A team led by Thomas Schulthess of the U.S. Depar...ceived the prestigious 2008 Association for Comput...er attaining the fastest performance ever in a sci... is group leader of ORNL,s Computational Materials... director of the Swiss National Supercomputing Cen...
(Date:11/20/2008)...n ageing population, and turning research into com...lion ($30.4 million) investment announced today by...uncil (EPSRC), Technology Strategy Board (TSB) and...h Council (BBSRC). , This new investment will cr...ientific breakthroughs have already been achieved....
(Date:11/19/2008)...rms, sponges, jellyfish - have the simplest eyes t... a photoreceptor cell and a pigment cell. These mi...yes, suggested by Charles Darwin as the first eyes...mages but allow the animal to sense the direction ...the swimming towards light exhibited by many zoopl...
Breaking Biology News(10 mins):DigitalPersona Places Identity Protection at People's Fingertips 2DigitalPersona Places Identity Protection at People's Fingertips 3ORNL supercomputer simulation wins prize for fastest-running science application 2ORNL supercomputer simulation wins prize for fastest-running science application 3£20 million to fight virtual crime and treat our aging population 2£20 million to fight virtual crime and treat our aging population 3Uncovering secrets of life in the ocean 2American Laser Centers Names Bill Van Huis as Chief Revenue Officer 12587 1American Laser Centers Names Bill Van Huis as Chief Revenue Officer 12587 2Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 12581 1Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 12581 2Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 12581 3Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 12581 4Strativa Pharmaceuticals a Division of Par Pharmaceutical Announces the Discontinuation of the Development Program for Pafuramidine 3479 1Strativa Pharmaceuticals a Division of Par Pharmaceutical Announces the Discontinuation of the Development Program for Pafuramidine 3479 2Strativa Pharmaceuticals a Division of Par Pharmaceutical Announces the Discontinuation of the Development Program for Pafuramidine 3479 3Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 1Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 2Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 3Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 4Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 5Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 6
...logists at New York University,s Center for Compar...e for the gene mel-28. The gene plays a part in en...g cell division and it is required for nuclear env... Current Biology. , The team is using functi...orhabditis elegans (C. elegans), the first animal ...
... habituated population of pied babblers (Turdoides... discovered a surprising new way in which parent b...ing. The findings are reported by Andrew Radford o... the University of Cape Town and appear in the Sep...Cell Press. , It is well known that birds feed t...
... may reduce female fertility by directly affecting... the chances the embryo will implant, according to...in Europe,s leading reproductive medicine journal ... fertility experts in Portugal and Spain, comes as... non-heavy smokers and heavy smokers, all of whom ...
...ailed experiment turned out to be anything but for...zling out why what should have been a routine proc...to the creation of a new biological tool for destr...r to trigger antibiotic resistance. , The discov...technology firm that has already brought Wisconsin...
Other Biology News:NYU biologists identify gene that coordinates two cellular processes 2Heavy smoking cuts women's chance of pregnancy -- even with donated oocytes 2Heavy smoking cuts women's chance of pregnancy -- even with donated oocytes 3'Failed' experiment yields a biocontrol agent that doesn't trigger antibiotic resistance 2'Failed' experiment yields a biocontrol agent that doesn't trigger antibiotic resistance 3
Finnigan LTQ FT from Thermo Scientific
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
Biology Products: